Bionaut Labs is a deeptech company engineering remote-controlled micro-robots designed to navigate inside the human body. Guided by an external magnetic field, these devices deliver therapeutic payloads - including biologics, nucleic acids, and small molecules - directly to targeted sites in the brain and central nervous system. The technology is being developed to treat neurological disorders where conventional delivery methods face significant barriers.
The company operates in the intersection of robotics, biologics delivery, and magnetic field control, with applications spanning neurology, oncology, and neurosurgery. Bionaut Labs has raised over $80 million in funding to date and maintains operations in Los Angeles and Israel. The team comprises engineers, biologists, and other specialists working on what is fundamentally a medical-device challenge at the frontier of precision medicine.
